Application Note: Nanobody structure, advantages, development and production
Nanobodies, also known as single-domain antibodies (sdAbs) or VHH antibodies, are only 1/10th the size of traditional monoclonal antibodies but can retain full antigen-binding potential, establishing them as the smallest-known functional antibody fragments. They possess attractive properties for a range of therapeutic and diagnostic applications.
In this Application Note on nanobodies, Sino Biological discusses their structure and types, advantages and limitations, clinical applications and development platforms.
Nanobody Structure, Advantages, Development, and Production_Sino Biological_compressed (1)
This content was provided by
Follow Sino Biological on LinkedIn and YouTube.
Submit Your Research to the F1000Research Oncology Gateway
Share your oncology research with the global scientific community through the F1000Research Oncology Gateway. With trusted publishing, open access, and transparent peer review, your work will uphold the highest standards of research integrity while driving innovation in cancer treatment and understanding.
Join a trusted platform that accelerates progress in oncology. Submit your research today at F1000Research Oncology Gateway.
